Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Multiple Comorbidities

被引：0

作者：

Glaspole, I. ^{[1
,2
]}

Bonella, F. ^{[3
]}

Bargagli, E. ^{[4
]}

Glassberg, M. K. ^{[5
]}

Caro, F. ^{[6
]}

Stansen, W. ^{[7
]}

Quaresma, M. ^{[8
]}

Orsatti, L. ^{[8
]}

Bendstrup, E. ^{[9
]}

机构：

[1] Alfred Hlth, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia

[2] Monash Univ, Dept Med, Melbourne, Vic, Australia

[3] Duisburg Essen Univ, Interstitial & Rare Lung Dis Unit, Ruhrlandklin, Univ Hosp, Essen, Germany

[4] Siena Univ Hosp, Sect Resp Dis & Lung Transplantat, Dept Clin Med & Neurosci, Siena, Italy

[5] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[6] Maria Ferrer Hosp, Buenos Aires, DF, Argentina

[7] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany

[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4549

引用

页数：2

共 50 条

[21] SHORT-TERM SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS [J].

Saji, J. ;

Okamoto, M. ;

Matsuzawa, S. ;

Oyama, B. ;

Onoe, R. ;

Kakinuma, K. ;

Azagami, S. ;

Muraoka, H. ;

Morikawa, K. ;

Takemura, M. ;

Inoue, T. ;

Kida, H. ;

Furuya, N. ;

Handa, H. ;

Nishine, H. ;

Ishida, A. ;

Inoue, T. ;

Miyazawa, T. ;

Mineshita, M. .

RESPIROLOGY, 2016, 21 :36-36

[22] Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data [J].

Lasky, Joseph A. ;

Criner, Gerard J. ;

Lazarus, Howard M. ;

Kohlbrenner, Veronika ;

Bender, Shaun ;

Richeldi, Luca .

ADVANCES IN THERAPY, 2020, 37 (10) :4209-4219

[23] Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data [J].

Joseph A. Lasky ;

Gerard J. Criner ;

Howard M. Lazarus ;

Veronika Kohlbrenner ;

Shaun Bender ;

Luca Richeldi .

Advances in Therapy, 2020, 37 :4209-4219

[24] Histologic factors associated with nintedanib efficacy in patients with idiopathic pulmonary fibrosis [J].

Nemoto, Masahiro ;

Zaizen, Yoshiaki ;

Kataoka, Kensuke ;

Kuroda, Kishio ;

Tabata, Kazuhiro ;

Bychkov, Andrey ;

Sumikawa, Hiromitsu ;

Johkoh, Takeshi ;

Aoshima, Masahiro ;

Kondoh, Yasuhiro ;

Fukuoka, Junya .

PLOS ONE, 2021, 16 (01)

[25] The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis [J].

Cottin, Vincent .

EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) :857-865

[26] Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis [J].

Ogura, Takashi ;

Taniguchi, Hiroyuki ;

Azuma, Arata ;

Inoue, Yoshikazu ;

Kondoh, Yasuhiro ;

Hasegawa, Yoshinori ;

Bando, Masashi ;

Abe, Shinji ;

Mochizuki, Yoshiro ;

Chida, Kingo ;

Klueglich, Matthias ;

Fujimoto, Tsuyoshi ;

Okazaki, Kotaro ;

Tadayasu, Yusuke ;

Sakamoto, Wataru ;

Sugiyama, Yukihiko .

EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) :1382-1392

[27] Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis [J].

Wells, Athol U. ;

Rosas, Ivan O. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (02) :112-113

[28] Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis [J].

Kawada, Tomoyuki .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) :1274-+

[29] Efficacy and safety of Nintedanib in idiopathic pulmonary fibrosis: A systematic review and meta-analysis [J].

Cheema, Shamikha ;

Saddique, Muhammad Nabeel ;

Jha, Anurag ;

Sehar, Ayesha ;

Cheema, Umaima ;

Shahid, Fatima ;

Hassan, Muhammad Faique ;

Javaid, Hammad ;

Lanari, Valeria Chiara ;

Nawaz, Ali .

HEART & LUNG, 2025, 73 :114-122

[30] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis (vol 370, pg 2071, 2014) [J].

Richeldi, Luca ;

du Bois, Roland M. ;

Raghu, Ganesh .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08) :782-782

← 1 2 3 4 5 →